$4.01
arrow_drop_up6.38%Key Stats | |
---|---|
Open | $4.03 |
Prev. Close | $3.76 |
EPS | -1.01 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $202.09M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 3.76 | 4.19 |
52 Week Range | 1.04 | 8.45 |
Ratios | |
---|---|
EPS | -1.01 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Sight Sciences to Report Second Quarter Financial Results on August 1, 2024 - GlobeNewswire
Sight Sciences CFO Alison Bauerlein sells over $65k in company stock By Investing.com - Investing.com
Sight Sciences Announces the Release of its First Sustainability Report
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates